Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
FEBS Letters
|
April 4, 2006
EKLF/KLF1 is ubiquitinated in vivo and its stability is regulated by activation domain sequences through the 26S proteasome
Karen J Quadrini, James J Bieker
The Journal of Biological Chemistry
|
June 20, 2002
Krüppel-like zinc fingers bind to nuclear import proteins and are required for efficient nuclear localization of erythroid Krüppel-like factor
Karen J Quadrini, James J Bieker
Experimental Cell Research
|
March 11, 2008
Non-random subcellular distribution of variant EKLF in erythroid cells
Karen J Quadrini, Eugenia Gruzglin, James J Bieker
Cytometry. Part B, Clinical Cytometry
|
January 12, 2021
A flow cytometric assay for HLA-DR expression on monocytes validated as a biomarker for enrollment in sepsis clinical trials
Karen J Quadrini, Lisa Patti-Diaz, Jasmin Maghsoudlou, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
August 2, 2007
IRX-2, a novel in vivo immunotherapeutic, induces maturation and activation of human dendritic cells in vitro
James E Egan, Karen J Quadrini, Frances Santiago-Schwarz, et al.
Cytometry. Part B, Clinical Cytometry
|
June 19, 2015
Validation of a flow cytometry-based assay to assess C5aR receptor occupancy on neutrophils and monocytes for use in drug development
Karen J Quadrini, Anne Charlotte Hegelund, Kasia E Cortes, et al.
Bioanalysis
|
August 12, 2025
Special consideration: commentary on the 2025 FDA Bioanalytical Method Validation for Biomarkers
Karen J Quadrini, Jiri Aubrecht, Nicholas M P King, et al.
The AAPS Journal
|
August 23, 2024
Best Practices for Development and Validation of Enzymatic Activity Assays to Support Drug Development for Inborn Errors of Metabolism and Biomarker Assessment
Mitra Azadeh, Jeremy Good, Michele Gunsior, et al.
Bioanalysis
|
March 10, 2026
Progress and promise of pharmacodynamic biomarkers: novel strategies and assay considerations in drug development
Carmen Fernández-Metzler, Karen J Quadrini, Lakshmi Amaravadi, et al.
Molecular Therapy. Methods & Clinical Development
|
September 16, 2024
Validation of high-sensitivity assays to quantitate cerebrospinal fluid and serum β-galactosidase activity in patients with GM1-gangliosidosis
Karen J Quadrini, Catherine Vrentas, Christian Duke, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
FEBS Letters
|
April 4, 2006
EKLF/KLF1 is ubiquitinated in vivo and its stability is regulated by activation domain sequences through the 26S proteasome
Karen J Quadrini, James J Bieker
The Journal of Biological Chemistry
|
June 20, 2002
Krüppel-like zinc fingers bind to nuclear import proteins and are required for efficient nuclear localization of erythroid Krüppel-like factor
Karen J Quadrini, James J Bieker
Experimental Cell Research
|
March 11, 2008
Non-random subcellular distribution of variant EKLF in erythroid cells
Karen J Quadrini, Eugenia Gruzglin, James J Bieker
Cytometry. Part B, Clinical Cytometry
|
January 12, 2021
A flow cytometric assay for HLA-DR expression on monocytes validated as a biomarker for enrollment in sepsis clinical trials
Karen J Quadrini, Lisa Patti-Diaz, Jasmin Maghsoudlou, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
August 2, 2007
IRX-2, a novel in vivo immunotherapeutic, induces maturation and activation of human dendritic cells in vitro
James E Egan, Karen J Quadrini, Frances Santiago-Schwarz, et al.
Cytometry. Part B, Clinical Cytometry
|
June 19, 2015
Validation of a flow cytometry-based assay to assess C5aR receptor occupancy on neutrophils and monocytes for use in drug development
Karen J Quadrini, Anne Charlotte Hegelund, Kasia E Cortes, et al.
Bioanalysis
|
August 12, 2025
Special consideration: commentary on the 2025 FDA Bioanalytical Method Validation for Biomarkers
Karen J Quadrini, Jiri Aubrecht, Nicholas M P King, et al.
The AAPS Journal
|
August 23, 2024
Best Practices for Development and Validation of Enzymatic Activity Assays to Support Drug Development for Inborn Errors of Metabolism and Biomarker Assessment
Mitra Azadeh, Jeremy Good, Michele Gunsior, et al.
Bioanalysis
|
March 10, 2026
Progress and promise of pharmacodynamic biomarkers: novel strategies and assay considerations in drug development
Carmen Fernández-Metzler, Karen J Quadrini, Lakshmi Amaravadi, et al.
Molecular Therapy. Methods & Clinical Development
|
September 16, 2024
Validation of high-sensitivity assays to quantitate cerebrospinal fluid and serum β-galactosidase activity in patients with GM1-gangliosidosis
Karen J Quadrini, Catherine Vrentas, Christian Duke, et al.
Page
of 2